{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:13:32Z","timestamp":1767665612293,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jvoice.2019.11.017","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T22:21:21Z","timestamp":1576362081000},"page":"618-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Use of Inhaled N-Acetylcysteine for Laryngopharyngeal Reflux Disease: A Randomized Controlled Trial"],"prefix":"10.1016","volume":"35","author":[{"given":"Yong Seok","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ick Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Kyoung","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2019.11.017_bib0001","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jama.294.12.1534","article-title":"Evaluation and management of laryngopharyngeal reflux","volume":"294","author":"Ford","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0892-1997(96)80001-4","article-title":"Laryngopharyngeal reflux: consensus conference report","volume":"10","author":"Koufman","year":"1996","journal-title":"J Voice"},{"issue":"Suppl 4a","key":"10.1016\/j.jvoice.2019.11.017_bib0003","doi-asserted-by":"crossref","first-page":"170S","DOI":"10.1016\/S0002-9343(99)00359-9","article-title":"Medical therapy of supraesophageal gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0004","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.otohns.2004.03.037","article-title":"Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial","volume":"131","author":"Steward","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0005","first-page":"S491","article-title":"A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease","volume":"6","author":"Berardi","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/13543784.11.1.15","article-title":"Mucoactive drugs for asthma and COPD: any place in therapy?","volume":"11","author":"Rogers","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.jvoice.2019.11.017_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000195085","article-title":"Acetylcysteine: a drug with an interesting past and a fascinating future","volume":"50","author":"Ziment","year":"1986","journal-title":"Respiration"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstrom","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0009","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects ofN-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0011","first-page":"757","article-title":"The effect of N-acetyl cysteine on laryngopharyngeal reflux","volume":"51","author":"Dabirmoghaddam","year":"2013","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0012","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0892-1997(02)00097-8","article-title":"Validity and reliability of the reflux symptom index (RSI)","volume":"16","author":"Belafsky","year":"2002","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0013","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00005537-200108000-00001","article-title":"The validity and reliability of the reflux finding score (RFS)","volume":"111","author":"Belafsky","year":"2001","journal-title":"Laryngoscope"},{"issue":"Suppl 4a","key":"10.1016\/j.jvoice.2019.11.017_bib0014","doi-asserted-by":"crossref","first-page":"112S","DOI":"10.1016\/S0002-9343(99)00349-6","article-title":"Diagnosis and management of chronic laryngitis associated with reflux","volume":"108","author":"Hanson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000441-200311000-00005","article-title":"Extraesophageal manifestations of GERD","volume":"326","author":"Napierkowski","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0016","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.gtc.2008.09.005","article-title":"Extraesophageal GERD","volume":"37","author":"Frye","year":"2008","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0017","first-page":"290","article-title":"Investigation of extraesophageal gastroesophageal reflux disease","volume":"26","author":"Tsoukali","year":"2013","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0018","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mlg.0000192173.00498.ba","article-title":"Treatment of chronic posterior laryngitis with esomeprazole","volume":"116","author":"Vaezi","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0019","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/01.MLG.0000163746.81766.45","article-title":"Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response","volume":"115","author":"Park","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0020","first-page":"962","article-title":"Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine","volume":"96","author":"Hurst","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0021","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09059180.00003510","article-title":"Mucoactive drugs","volume":"19","author":"Balsamo","year":"2010","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0022","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.03.00063402","article-title":"N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease","volume":"21","author":"Gerrits","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0023","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-3003.2000.16b12.x","article-title":"The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review","volume":"16","author":"Stey","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0024","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/15412550600977361","article-title":"N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease","volume":"3","author":"Sutherland","year":"2006","journal-title":"COPD"},{"key":"10.1016\/j.jvoice.2019.11.017_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thx.46.1.39","article-title":"Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine","volume":"46","author":"Bridgeman","year":"1991","journal-title":"Thorax"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719304667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719304667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:37:09Z","timestamp":1760211429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199719304667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0892199719304667"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2019.11.017","relation":{},"ISSN":["0892-1997"],"issn-type":[{"type":"print","value":"0892-1997"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Inhaled N-Acetylcysteine for Laryngopharyngeal Reflux Disease: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2019.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}